I agree that this site is using cookies. You can find further informations here.
X
Farouk, Samar
160  results:
Search for persons X
?
1

Practical Recommendations from the Gulf Region on the Thera..:

Yamout, Bassem ; Alroughani, Raed ; Inshasi, Jihad...
Neurology and Therapy.  , 2024
Link: https://doi.org/10.1007/..
 
?
2

The clinical profile of new-onset optic neuritis in arabs, ..:

Behbehani, Raed ; Ali, Abdullah ; Alakool, Ahmed..
Heliyon.  10 (2024)  13 - p. e33985 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Time Requirements of Healthcare Professionals for Managing ..:

Abdelmoneim, Mohamed Sayed ; Canibano, Beatriz Garcia ; Farouk, Samar...
Multiple Sclerosis and Related Disorders.  80 (2023)  - p. 105317 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Multicentre Observational Study of Treatment Satisfaction w..:

Inshasi, Jihad ; Farouk, Samar ; Shatila, Ahmed...
Neurology and Therapy.  12 (2023)  4 - p. 1309-1318 , 2023
Link: https://doi.org/10.1007/..
 
?
5

Use of Traditional Medicine for Primary Headache Disorders ..:

Alshawaf, Fatemah ; Al-Hashel, Jasem ; Farouk, Samar.
Neurology.  92 (2019)  15_supplement - p. , 2019
Link: https://doi.org/10.1212/..
 
?
6

Safety and effectiveness of disease-modifying therapies aft..:

Zeineddine, Maya ; Al-Roughani, Raed ; Farouk Ahmed, Samar...
Multiple Sclerosis Journal.  30 (2024)  8 - p. 1026-1035 , 2024
Link: https://doi.org/10.1177/..
 
?
7

COVID-19 vaccination in people with multiple sclerosis, rea..:

Alroughani, Raed ; Al-Hashel, Jasem ; Abokalawa, Fathi..
Clinical Neurology and Neurosurgery.  220 (2022)  - p. 107374 , 2022
Link: https://doi.org/10.1016/..
 
?
8

Prevalence, severity, outcomes, and risk factors of COVID-1..:

Alroughani, Raed ; Inshasi, Jihad ; Al-Hashel, Jasem...
Journal of Clinical Neuroscience.  99 (2022)  - p. 311-316 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Onabotulinumtoxin A Improves Psychological Aspects in Chron..:

Al-Hashel, Jasem Youssef ; Kh Ashkanani, Hasan ; Almutairi, Ohood...
Frontiers in Neurology.  11 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
10

Substantial and comparable suppression of disease activity ..:

Alroughani, Raed ; Al-Hashel, Jasem ; Ahmed, Samar Farouk
Clinical Neurology and Neurosurgery.  240 (2024)  - p. 108249 , 2024
Link: https://doi.org/10.1016/..
 
?
11

Disease-Modifying Therapies, Outcomes, Risk Factors and Sev..:

Zeineddine, Maya ; Al-Hajje, Amal ; Salameh, Pascale...
Multiple Sclerosis and Related Disorders.  , 2024
Link: https://doi.org/10.1016/..
 
?
12

Real-Life Study with Alemtuzumab, Kuwait Experience:

Alroughani, Raed ; Al-Hashel, Jasem ; Almojel, Malak.
Multiple Sclerosis and Related Disorders.  71 (2023)  - p. 104365 , 2023
Link: https://doi.org/10.1016/..
 
?
13

Ocrelizumab for Pediatric Relapsing Multiple Sclerosis:

Alroughani, Raed ; Almojel, Malak ; Al-Hashel, Jasem.
Multiple Sclerosis and Related Disorders.  80 (2023)  - p. 105269 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Early Initiation of High Efficacy Disease Modifying Therapi..:

Alroughani, Raed ; Al-Hashel, Jasem ; Ahmed, Samar Farouk
Multiple Sclerosis and Related Disorders.  80 (2023)  - p. 105326 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Real World Study of Ocrelizumab in Multiple Sclerosis: Kuwa..:

Alroughani, Raed ; Almojel, Malak ; Al-Hashel, Jasem.
Multiple Sclerosis and Related Disorders.  80 (2023)  - p. 105327 , 2023
Link: https://doi.org/10.1016/..
 
1-15